Form 4: Strategy Inc director exercises and sells 700

Strategy Inc director Jarrod M. Patten exercised 700 options at $18.654 and sold 700 Class A shares at $137.37 on March 26, 2026, with no net change in common shares held.

Summary

• Director Jarrod M. Patten exercised 700 director stock options at $18.654 per share on 03/26/2026 (transaction code M) and immediately sold 700 Class A Common shares at $137.37 per share (transaction code S).
• Post-transactions, direct ownership of Class A Common Stock remained 28,000 shares.
• Patten continues to hold 49,300 director stock options following the exercise; the option grant expires on 05/31/2026.
• Vesting details: 700 exercised shares vested on 05/31/2017; of the remaining 49,300 options, 11,800 vested on 05/31/2017 and 12,500 vested on each of 05/31/2018, 05/31/2019, and 05/31/2020.
• Reported direct preferred holdings: 10,000 shares of Series A Perpetual Strife Preferred Stock; 29,335 shares of Series A Perpetual Stretch Preferred Stock; 5,000 shares of Series A Perpetual Stride Preferred Stock.
• A Power of Attorney was filed authorizing Thomas Chow, Andrew Kang, and Allein Sabel to execute Section 16 forms on Patten’s behalf; Patten signed the POA on March 27, 2026 and the Form 4 was signed by attorney-in-fact on 03/30/2026.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as modestly positive-to-neutral: a small, routine insider sale matched to an option exercise with sizable remaining ownership and options.

Positives

• No net change in Class A Common ownership (remains 28,000 shares) despite the exercise and same-day sale.
• Exercise price ($18.654) is significantly below the reported sale price ($137.37), indicating in-the-money options.
• Director maintains sizable exposure via 49,300 remaining options (expiring 05/31/2026) and preferred holdings (total 44,335 shares across three Series A classes).
• Power of Attorney in place may improve timeliness and accuracy of future Section 16 filings.

Negatives

• Open market sale by a director (700 shares) can be perceived negatively by some investors despite its small size.
• Option expiration on 05/31/2026 suggests time-limited window to exercise remaining options.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that same-day option exercise-and-sell transactions by insiders are common across U.S. public companies for liquidity or tax purposes and, when small relative to total holdings and absent a pattern, are typically interpreted as neutral signals.

Comparison to Industry Standards

• Transaction size (700 shares) is small and aligns with routine insider liquidity events commonly observed among directors at U.S.-listed companies.
• A no-net-change outcome in common holdings after paired exercise and sale is typical and generally seen as neutral, compared with larger discretionary disposals that can be more negatively interpreted.
• Maintaining substantial residual option exposure (49,300 options) is consistent with standard director incentive alignment practices across mid-to-large cap issuers.

Corporate Governance

Stakeholder Impact

• Minimal immediate impact on shareholders, as the sale is small and offset by the exercise (no net change in common holdings).
• No indication of company-level capital raising or dilution from this insider sale; activity reflects personal trading.
• POA may enhance filing timeliness for regulators and investors monitoring insider activity.

Next Steps

• Monitor for additional exercises or sales ahead of the 05/31/2026 option expiration.

Key Dates

Keywords

insider transaction, Form 4, Strategy Inc, MSTR, director stock option, open market sale, Class A Common Stock, preferred stock, Section 16, Power of Attorney, beneficial ownership